Conference to Clinic Roundtable: Applying the Latest Data Developments for Therapies Targeting TROP-2 and TIGIT in Lung Cancer

Gain expert insights into patients with lung cancer who will mostly likely benefit from novel therapies targeting TROP-2 and TIGIT based on recent data to enhance clinical outcomes through a certified on-demand webcast, expert-authored ClinicalThought commentary, and downloadable slides.

Share

Program Content

Events

  • Live Event Conference to Clinic Roundtable
    Conference to Clinic Roundtable: Applying the Latest Data Developments for Therapies Targeting TROP-2 and TIGIT in Lung Cancer
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

Lung Cancer Therapies Targeting TROP2 and TIGIT
Conference to Clinic Roundtable: Applying the Latest Data Developments for Therapies Targeting TROP-2 and TIGIT in Lung Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 16, 2025

Expires: May 15, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.